(Q35995313)

English

Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

author name string

Yuh-Min Chen

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Wen-Chien Fan

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Pei-Chun Tseng

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Chun-Ming Tsai

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Teh-Ying Chou

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Chieh-Hung Wu

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Kun-Ta Chou

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Yu-Chin Lee

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Reury-Perng Perng

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Jacqueline Whang-Peng

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

23 December 2011

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Oncology Letters

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

713-717

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362392

2 October 2017

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362392

2 October 2017

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362392

2 October 2017

Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362392

2 October 2017

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362392

2 October 2017

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362392

2 October 2017

EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362392

23 September 2018

Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362392

23 September 2018

Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362392

23 September 2018

Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method

1 reference

https://pubmed.ncbi.nlm.nih.gov/22740981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22740981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/OL.2011.534

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

release_3boaaztbsbdcbhgn6bveyg2rhm

1 reference

https://api.fatcat.wiki/v0/release/3boaaztbsbdcbhgn6bveyg2rhm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35995313&oldid=1977299131"